openPR Logo

Press Releases from CROS NT (5 total)

11-26-2010 | Health & Medicine
CROS NT

CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010

Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”. Vezzoli’s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be used
11-23-2010 | Health & Medicine
CROS NT

CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS

Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.

CROS NT Group launches Arithmos s.r.l. to keeping up with the new Innovation’s …

CROS NT Group launches Arithmos s.r.l., a start up company created at the beginning of 2010 with the aim to play an active role as information technology service provider within the pharmaceutical and biotechnology environment. Inheriting CROS NT’s 15 years experience and developing a strong sensibility for innovation investments, today Arithmos is a valuable partner to optimize companies performances and accelerate their growth into the market in an accurate, safe and
07-29-2010 | Health & Medicine
CROS NT

CROS NT appoints new Vice President for Germany

CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team

CROS NT Announces its Expansion into German Market Creating CROS DE GmbH

CROS NT is pleased to announce its expansion into Europe through the creation of CROS DE GmbH, a new wholly-owned subsidiary based in Augsburg, Germany. The company, born from the experience of a German-based CRO, Estimate GmbH, is specialized in providing statistical services to pharmaceuticals and biotechnology industries. Estimate enrich CROS NT with its expertise and a particular excellence concerning the oncology and dermatology-related research. Estimate was found in 1992

Go To Page:   1 2 3 4 5 6 7 8 9 10